Allied Market Research
Loading...
0
New
New
2021
Artificial Cornea And Corneal Implant Market

Artificial Cornea and Corneal Implant Market by Type (Human Cornea and Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior Lamellar Keratoplasty, and Keratoprosthesis), Disease Indication (Fuchs' Dystrophy, Fungal Keratitis, Keratoconus, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics): Global Opportunity Analysis and Industry Forecast, 2021–2028

A11333
Pages: 215
May 2021 | 606 Views
   
Author(s) : Apoorva Srivastava, Ravi Telugunta , Onkar Sumant
Tables: 129
Charts: 29
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Artificial Cornea And Corneal Implant Market

Request Now !

Artificial Cornea and Corneal Implant Market Overview:

The global artificial cornea and corneal implant market generated $376.61 million in 2020 and is projected to reach $656.19 million by 2028, growing at a CAGR of 7.9% from 2021 to 2028.

Decline in the number of elective eye surgeries and decrease in cornea donation is expected to create a negative impact on the market.

The growth in the artificial cornea implant market is attributed to the willingness of the customer to spend on eye care. Furthermore, increase in prevalence of ophthalmic diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the key factor that propels the market growth. Apart from this, increase in healthcare expenditure on eye care in the developing countries boosts the growth of the global artificial cornea implant market. In addition, factors such as increase in number of surgeries and rise in demand for new techniques for the treatment provides growth opportunities for the market. However, high cost associated with cornea implant surgeries poses a threat toward the growth of the global artificial cornea implant market. In addition, side effects of the cornea surgeries prevents mass adoption of cornea implant.

Artificial-Cornea-and-Corneal-Implant-Market,-2021-2028

Get more information on this report : Request Sample Pages

According to the NCBI report, approximately 10-15% of the patients diagnosed with keratoconus have to undergo corneal implant procedure at some point. Corneal blindness is the third leading cause of blindness after glaucoma and cataract affecting 10 million people globally. It is estimated that around 200,000 corneal implant procedures are performed annually. Whereas, still 12.7 million patients are waiting for corneal implants. Furthermore, increase in awareness about the importance of eye donation is expected to boost the market growth. In addition, improvement of eye care facilities, eye banking framework, and cornea trade protocols in the developing countries is expected to contribute toward the rise in demand, thereby supporting the market growth.

The key market players operating in the artificial cornea and corneal implant market are supporting the health systems and healthcare professionals actively attributed to the prevalence of coronavirus (COVID-19) throughout the global community,. During the initial phases of the COVID-19 pandemic, governments across the globe issued limitations and bans on medical procedures and elective surgeries to stop the widely spreading virus. Due to these restrictions, artificial cornea manufacturers faced problems in conducting in-person product demonstrations, operating their facilities at full capacity, and attending or organizing conferences. Moreover, lockdowns in the Asia-Pacific countries such as China and India delayed the production and shipment of ophthalmic devices. These restrictions hampered the demand for ophthalmic procedures.

Rise in geriatric population susceptible to eye diseases drive the artificial cornea and corneal implant industry growth. Moreover, technological advancements coupled with surge in incidence of eye diseases on global level further boost the growth of the corneal implants industry growth. Presence of organizations such as Eye Bank Association of America (EBAA) and The Global Alliance of Eye Bank Associations to promote policies for encouraging effective corneal transplantation render positive impact on the business growth. In addition, rise in awareness regarding eye disease diagnosis is projected to favor corneal implants industry growth during the forecast period.

Furthermore, surge in demand for minimally invasive surgical procedure across the globe is anticipated to positively impact the market growth. Advantages associated with minimally invasive treatments coupled with rise in awareness regarding corneal transplants that provide aesthetic benefits boost the industry growth. Advantages include sharper vision by the first day after surgical procedure, enhanced visual recovery, and reduced risk of rejection. Such advantages drive patient preference for corneal implants thereby, fueling the artificial cornea and corneal implant market growth.

Artificial Cornea And Corneal Implant Market Segmentation

The artificial cornea and corneal implant market is segmented on the basis of type, transplant type, disease indication, end user, and region. By type, the market is divided into human cornea and artificial cornea. By transplant type, it is categorized into penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty and keratoprosthesis. By disease indication, the market is divided into Fuchs' Dystrophy, Fungal Keratitis, Keratoconus and others. By end user, the market is segmented into hospitals, ambulatory surgical centers, and speciality clinics. On the basis of region, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment review

On the basis of type, the human cornea segment is expected to maintain its dominant position throughout the forecast period attributed to the rise in awareness regarding corneal transplantation and eye tissue donations, especially in the developing economies. In addition, by transplant type, the penetrating keratoplasty segment dominated the artificial cornea and corneal implant market in 2019, owing to the adoption of penetrating keratoplasty in the treatment of various corneal pathologies including keratoconus, bullous keratopathy and dystrophies. This is expected to boost the segment growth.

Artificial Cornea and Corneal Implant Market
By Type

Your browser does not support the canvas element.

Human Cornea is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

By end user, the speciality clinics segment is expected to grow at the highest CAGR during the forecast period attributed to rise in reluctance to in-patient surgeries and demand for minimally invasive procedures.

Patient preference toward effective treatment and concerns regarding hospital-acquired infections further favor the artificial cornea and corneal implant market growth during the forecast period.

Artificial Cornea and Corneal Implant Market
By Transplant Type

Your browser does not support the canvas element.

Penetrating Keratoplasty is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific Artificial Cornea and Corneal Implant Market

Asia-Pacific presents lucrative opportunities for the key players operating in the artificial cornea and corneal implant market, owing to rise in population, particularly geriatric population along with large patient pool in the region suffering from various eye diseases offering numerous growth opportunities to players operating in the corneal implants market. Moreover, various programs for efficient eye-banking skills organized by eye banks and other organizations further drive the Asia Pacific corneal implants industry growth during the forecast period.

The report provides a comprehensive analysis of the leading companies operating in the market are AJL Ophthalmic, CorneaGen Inc., CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab, Cornea Biosciences, DIOPTEX GmbH, and EyeYon Medical.

Artificial Cornea and Corneal Implant Market
By Region

2028
North America 
Europe
Asia Pacific
Lamea

Asia Pacific region would exhibit the highest CAGR of 8.7% during 2021-2028.

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • The report provides an extensive analysis of the artificial cornea and corneal implant market size, current market trends and future estimations of the market.
  • The artificial cornea and corneal implant market analysis is comprehensively covered with respect to the component, application, and region.
  • The artificial cornea and corneal implant estimations in this report are based on high-end analysis of the key developments for 2020–2028.
  • Recent developments, key manufacturers, and top player positioning are listed in this report to analyze the competitive scenario of the artificial cornea and corneal implant market.

Key Market Segments

By Type

  • Human Cornea
  • Artificial Cornea 

By Transplant Type

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty
  • Anterior lamellar keratoplasty
  • keratoprosthesis

By Disease Indication

  • Fuchs' Dystrophy
  • Fungal Keratitis
  • Keratoconus
  • Others

By End User

  • Hospitals & Ambulatory Surgical Centers
  • Specialty Clinics

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key Findings of the Study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Rise in prevalence of eye diseases across the globe
3.4.1.2.Surge in government initiatives to control visual impairment
3.4.1.3.Growth in geriatric population

3.4.2.Restraints

3.4.2.1.High cost of ophthalmology devices and surgical procedures
3.4.2.2.Low accessibility to eye care in low income countries

3.4.3.Opportunity

3.4.3.1.Shortage of corneal donors

3.5.COVID-19 impact on the artificial cornea and corneal implant market

CHAPTER 4:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Human Cornea

4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Artificial Cornea

4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

CHAPTER 5:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Penetrating Keratoplasty

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Endothelial Keratoplasty

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Anterior lamellar keratoplasty

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

5.5.keratoprosthesis

5.5.1.Market size and forecast
5.5.2.Market analysis, by country

CHAPTER 6:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Fuchs’ Dystrophy

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.FUNGAL KERATITIS

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Keratoconus

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

6.5.Other Diseases

6.5.1.Market size and forecast
6.5.2.Market analysis, by country

CHAPTER 7:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Hospitals & Ambulatory Surgical Centers

7.2.1.Market size and forecast
7.2.2.Market analysis, by country

7.3.Specialty Clinics

7.3.1.Market size and forecast
7.3.2.Market analysis, by country

CHAPTER 8:ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends and opportunities
8.2.2.Market size and forecast, by country
8.2.3.North America artificial cornea and corneal implant market by Type
8.2.4.North America artificial cornea and corneal implant market by Transplant Type
8.2.5.North America artificial cornea and corneal implant market by Disease Indication
8.2.6.North America artificial cornea and corneal implant market by end user

8.2.6.1.U.S.

8.2.6.1.1.U.S. artificial cornea and corneal implant market by Type
8.2.6.1.2.U.S. artificial cornea and corneal implant market by Transplant Type
8.2.6.1.3.U.S. artificial cornea and corneal implant market by Disease Indication
8.2.6.1.4.U.S. artificial cornea and corneal implant market by end user

8.2.6.2.Canada

8.2.6.2.1.Canada artificial cornea and corneal implant market by Type
8.2.6.2.2.Canada artificial cornea and corneal implant market by Transplant Type
8.2.6.2.3.Canada artificial cornea and corneal implant market by Disease Indication
8.2.6.2.4.Canada artificial cornea and corneal implant market by end user

8.2.6.3.Mexico

8.2.6.3.1.Mexico artificial cornea and corneal implant market by Type
8.2.6.3.2.Mexico artificial cornea and corneal implant market by Transplant Type
8.2.6.3.3.Mexico artificial cornea and corneal implant market by Disease Indication
8.2.6.3.4.Mexico artificial cornea and corneal implant market by end user

8.3.Europe

8.3.1.Key market trends and opportunities
8.3.2.Market size and forecast, by country
8.3.3.Europe artificial cornea and corneal implant market by Type
8.3.4.Europe artificial cornea and corneal implant market by Transplant Type
8.3.5.Europe artificial cornea and corneal implant market by Disease Indication
8.3.6.Europe artificial cornea and corneal implant market by end user

8.3.6.1.Germany

8.3.6.1.1.Germany artificial cornea and corneal implant market by Type
8.3.6.1.2.Germany artificial cornea and corneal implant market by Transplant Type
8.3.6.1.3.Germany artificial cornea and corneal implant market by Disease Indication
8.3.6.1.4.Germany artificial cornea and corneal implant market by end user

8.3.6.2.France

8.3.6.2.1.France artificial cornea and corneal implant market by Type
8.3.6.2.2.France artificial cornea and corneal implant market by Transplant Type
8.3.6.2.3.France artificial cornea and corneal implant market by Disease Indication
8.3.6.2.4.France artificial cornea and corneal implant market by end user

8.3.6.3.UK

8.3.6.3.1.UK artificial cornea and corneal implant market by Type
8.3.6.3.2.UK artificial cornea and corneal implant market by Transplant Type
8.3.6.3.3.UK artificial cornea and corneal implant market by Disease Indication
8.3.6.3.4.UK artificial cornea and corneal implant market by end user

8.3.6.4.Rest of Europe

8.3.6.4.1.Rest of Europe artificial cornea and corneal implant market by Type
8.3.6.4.2.Rest of Europe artificial cornea and corneal implant market by Transplant Type
8.3.6.4.3.Rest of Europe artificial cornea and corneal implant market by Disease Indication
8.3.6.4.4.Rest of Europe artificial cornea and corneal implant market by end user

8.4.Asia-Pacific

8.4.1.Key market trends and opportunities
8.4.2.Market size and forecast, by country
8.4.3.Asia-Pacific artificial cornea and corneal implant market by Type
8.4.4.Asia-Pacific artificial cornea and corneal implant market, by Transplant Type
8.4.5.Asia-Pacific artificial cornea and corneal implant market, by Disease Indication
8.4.6.Asia-Pacific artificial cornea and corneal implant market by end user

8.4.6.1.Japan

8.4.6.1.1.Japan artificial cornea and corneal implant market by Type
8.4.6.1.2.Japan artificial cornea and corneal implant market by Transplant Type
8.4.6.1.3.Japan artificial cornea and corneal implant market by Disease Indication
8.4.6.1.4.Japan artificial cornea and corneal implant market by end user

8.4.6.2.China

8.4.6.2.1.China artificial cornea and corneal implant market by Type
8.4.6.2.2.China artificial cornea and corneal implant market by Transplant Type
8.4.6.2.3.China artificial cornea and corneal implant market by Disease Indication
8.4.6.2.4.China artificial cornea and corneal implant market by end user

8.4.6.3.Australia

8.4.6.3.1.Australia artificial cornea and corneal implant market by Type
8.4.6.3.2.Australia artificial cornea and corneal implant market by Transplant Type
8.4.6.3.3.Australia artificial cornea and corneal implant market by Disease Indication
8.4.6.3.4.Australia artificial cornea and corneal implant market by end user

8.4.6.4.India

8.4.6.4.1.India artificial cornea and corneal implant market by Type
8.4.6.4.2.India artificial cornea and corneal implant market by Transplant Type
8.4.6.4.3.India artificial cornea and corneal implant market by Disease Indication
8.4.6.4.4.India artificial cornea and corneal implant market by end user

8.4.6.5.Rest of Asia-Pacific

8.4.6.5.1.Rest of Asia-Pacific artificial cornea and corneal implant market by Type
8.4.6.5.2.Rest of Asia-Pacific artificial cornea and corneal implant market by Transplant Type
8.4.6.5.3.Rest of Asia-Pacific artificial cornea and corneal implant market by Disease Indication
8.4.6.5.4.Rest of Asia-Pacific artificial cornea and corneal implant market by end user

8.5.LAMEA

8.5.1.Key market trends and opportunities
8.5.2.Market size and forecast, by country
8.5.3.LAMEA artificial cornea and corneal implant market by Type
8.5.4.LAMEA artificial cornea and corneal implant market by Transplant Type
8.5.5.LAMEA artificial cornea and corneal implant market by Disease Indication
8.5.6.LAMEA artificial cornea and corneal implant market by end user

8.5.6.1.Brazil

8.5.6.1.1.Brazil artificial cornea and corneal implant market by Type
8.5.6.1.2.Brazil artificial cornea and corneal implant market by Transplant Type
8.5.6.1.3.Brazil artificial cornea and corneal implant market by Disease Indication
8.5.6.1.4.Brazil artificial cornea and corneal implant market by end user

8.5.6.2.Saudi Arabia

8.5.6.2.1.Saudi Arabia artificial cornea and corneal implant market, by Type
8.5.6.2.2.Saudi Arabia artificial cornea and corneal implant market, by Transplant Type
8.5.6.2.3.Saudi Arabia artificial cornea and corneal implant market, by Disease Indication
8.5.6.2.4.Saudi Arabia artificial cornea and corneal implant market, by end user

8.5.6.3.South Africa

8.5.6.3.1.South Africa artificial cornea and corneal implant market by Type
8.5.6.3.2.South Africa artificial cornea and corneal implant market, by Transplant Type
8.5.6.3.3.South Africa artificial cornea and corneal implant market, by Disease Indication
8.5.6.3.4.South Africa artificial cornea and corneal implant market, by end user

8.5.6.4.Rest of LAMEA

8.5.6.4.1.Rest of LAMEA artificial cornea and corneal implant market by Type
8.5.6.4.2.Rest of LAMEA artificial cornea and corneal implant market by Transplant Type
8.5.6.4.3.Rest of LAMEA artificial cornea and corneal implant market by Disease Indication
8.5.6.4.4.Rest of LAMEA artificial cornea and corneal implant market by end user

CHAPTER 9:COMPANY PROFILES

9.1.AJL Ophthalmic

9.1.1.Company overview
9.1.2.Company snapshot
9.1.4.Product portfolio

9.2.CorneaGen Inc

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segment
9.2.4.Product portfolio
9.2.5.Key strategic moves and developments

9.3.CorNeat Vision

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio

9.4.LinkoCare Life Sciences AB

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio

9.5.Presbia plc

9.5.1.Company overview
9.5.2.Operating business segments
9.5.3.Product portfolio

9.6.Mediphacos

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio

9.7.Aurolab

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance

9.8.Cornea Biosciences  

9.8.1.Company snapshot
9.8.2.Operating business segments
9.8.3.Product portfolio

9.9.DIOPTEX GmbH

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio

9.10.EyeYon Medical

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio

LIST OF TABLES

TABLE 01.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020–2028 ($MILLION)
TABLE 02.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HUMAN CORNEA TYPE, BY REGION, 2020–2028 ($MILLION)
TABLE 03.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ARTIFICIAL CORNEA TYPE, BY REGION, 2020–2028 ($MILLION)
TABLE 04.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020–2028 ($MILLION)
TABLE 05.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR PENETRATING KERATOPLASTY, BY REGION, 2020–2028 ($MILLION)
TABLE 06.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ENDOTHELIAL KERATOPLASTY, BY REGION, 2020–2028 ($MILLION)
TABLE 07.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020–2028 ($MILLION)
TABLE 08.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUCHS’ DYSTROPHY, BY REGION, 2020–2028 ($MILLION)
TABLE 09.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUNGAL KERATITIS, BY REGION, 2020–2028 ($MILLION)
TABLE 10.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR KERATOCONUS, BY REGION, 2020–2028 ($MILLION)
TABLE 11.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020–2028 ($MILLION)
TABLE 12.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2028 ($MILLION)
TABLE 13.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR SPECIALTY CLINICS, BY REGION, 2020–2028 ($MILLION)
TABLE 14.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR OTHERS, BY REGION, 2020–2028 ($MILLION)
TABLE 15.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY REGION, 2020–2028 ($MILLION)
TABLE 16.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 17.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 18.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 19.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 20.NORTH AMERICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 21.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 22.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 23.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 24.U.S. ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 25.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 26.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 27.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 28.CANADA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 29.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 30.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 31.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 32.MEXICO ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 33.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 34.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 35.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 36.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 37.EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 38.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 39.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 40.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 41.GERMANY ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 42.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 43.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 44.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 45.FRANCE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 46.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 47.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 48.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 49.UK ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 50.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 51.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 52.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 53.REST OF EUROPE ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 54.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 55.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 56.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 57.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 58.ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 59.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 60.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 61.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 62.JAPAN ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 63.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 64.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 65.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 66.CHINA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 67.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 68.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 69.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 70.AUSTRALIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 71.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 72.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 73.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 74.INDIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 75.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 76.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 77.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 78.REST OF ASIA-PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 79.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 80.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 81.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 82.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 83.LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 84.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 85.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 86.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 87.BRAZIL ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 88.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 89.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 90.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 91.SAUDI ARABIA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 92.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 93.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 94.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 95.SOUTH AFRICA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 96.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TYPE, 2020-2028 ($MILLION)
TABLE 97.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY TRANSPLANT TYPE, 2020-2028 ($MILLION)
TABLE 98.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY DISEASE INDICATION, 2020-2028 ($MILLION)
TABLE 99.REST OF LAMEA ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 100.AJL OPHTHALMIC: COMPANY SNAPSHOT
TABLE 101.AJL OPHTHALMIC: OPERATING SEGMENTS
TABLE 102.AJL OPHTHALMIC: PRODUCT PORTFOLIO
TABLE 103.CORNEAGEN INC: COMPANY SNAPSHOT
TABLE 104.CORNEAGEN INC: OPERATING SEGMENTS
TABLE 105.CORNEAGEN INC: PRODUCT PORTFOLIO
TABLE 106.CORNEAT VISION: COMPANY SNAPSHOT
TABLE 107.CORNEAT VISION : OPERATING SEGMENT
TABLE 108.CORNEAT VISION: PRODUCT PORTFOLIO
TABLE 109.LINKOCARE LIFE SCIENCES AB: COMPANY SNAPSHOT
TABLE 110.LINKOCARE LIFE SCIENCES AB: OPERATING SEGMENTS
TABLE 111.LINKOCARE LIFE SCIENCES AB: PRODUCT PORTFOLIO
TABLE 112.PRESBIA PLC: COMPANY SNAPSHOT
TABLE 113.PRESBIA PLC: OPERATING SEGMENTS
TABLE 114.PRESBIA PLC: PRODUCT PORTFOLIO
TABLE 115.MEDIPHACOS: COMPANY SNAPSHOT
TABLE 116.MEDIPHACOS: OPERATING SEGMENTS
TABLE 117.MEDIPHACOS: PRODUCT PORTFOLIO
TABLE 118.AUROLAB: COMPANY SNAPSHOT
TABLE 119.AUROLAB: OPERATING SEGMENTS
TABLE 120.AUROLAB: PRODUCT PORTFOLIO
TABLE 121.CORNEA BIOSCIENCES: COMPANY SNAPSHOT
TABLE 122.CORNEA BIOSCIENCES: OPERATING SEGMENTS
TABLE 123.CORNEA BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 124.DIOPTEX GMBH: COMPANY SNAPSHOT
TABLE 125.DIOPTEX GMBH: OPERATING SEGMENTS
TABLE 126.DIOPTEX GMBH: PRODUCT PORTFOLIO
TABLE 127.EYEYON MEDICAL: COMPANY SNAPSHOT
TABLE 128.EYEYON MEDICAL: OPERATING SEGMENTS
TABLE 129.EYEYON MEDICAL: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET: SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.MODERATE BARGAINING POWER OF BUYERS
FIGURE 04.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05.LOW THREAT OF NEW ENTRANTS
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.MODERATE COMPETITIVE RIVALRY
FIGURE 08.MARKET DYNAMICS: ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET
FIGURE 09.PREVALENCE OF FUNGAL KERATITIS (CHRONIC BRONCHITIS AND EMPHYSEMA) AMONG AMERICANS, 2020
FIGURE 10.NUMBER OF PERSONS AGED 65 YEARS OR OVER BY GEOGRAPHIC REGION, 2020 AND 2050
FIGURE 11.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HUMAN CORNEA TYPE, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 12.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ARTIFICIAL CORNEA TYPE, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR PENETRATING KERATOPLASTY, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR ENDOTHELIAL KERATOPLASTY, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUCHS’ DYSTROPHY, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR FUNGAL KERATITIS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR KERATOCONUS, BY COUNTRY,  2020 & 2028 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR HOSPITALS & AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020 & 2028 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET FOR OTHERS, BY COUNTRY,  2020 & 2028 ($MILLION)
FIGURE 21.HILL-ROM: NET SALES, 2018–2020 ($MILLION)
FIGURE 22.HILL-ROM: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 23.HILL-ROM: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 24.SMITHS MEDICAL: NET SALES, 2018–2020 ($MILLION)
FIGURE 25.SMITHS MEDICAL: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 26.SMITHS MEDICAL: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 27.TELEFLEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 28.TELEFLEX: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 29.TELEFLEX: REVENUE SHARE, BY REGION, 2020 (%)

 
 

This section provides the opinions of the top-level CXOs in the artificial cornea and corneal implant industry. According to the CXOs, market growth is largely driven by the rise in geriatric population and increase in prevalence of ophthalmic diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, are the major drivers for the artificial cornea and corneal implants market. However, the high cost of ophthalmology devices and surgical procedures is expected to restrain the growth of the market during the forecast period.

According to the perspectives of CXOs of leading companies in the market, rise in prevalence of eye diseases along with the technological advancements in corneal implant devices are the key contributors to the market growth. In addition, increase in government initiatives to control visual impairment are anticipated to increase awareness regarding available latest technologies among patients suffering from eye-associated disorders. Conversely, less accessibility to eye care in low income countries pose a restrain to the market. Whereas, development of advanced artificial cornea by the key manufacturers is expected to open up new avenues for the expansion of the artificial cornea and corneal implant market.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. Top companies such as AJL Ophthalmic, CorneaGen Inc., CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab, Cornea Biosciences, DIOPTEX GmbH, EyeYon Medical.

A. In transplant type, penetrating keratoplasty segment is the most influencing segment. This segment is expected to exhibit a prominent growth rate, owing to the rising number of people suffering from eye disorders such as infectious keratitis and injury of the eyeball.

A. The major factor that fuels the growth of the Global Artificial Cornea and Corneal Implant Market includes Rising prevalence of eye diseases, increase in gariatric population and others. furthermore, new product launches to flourish the market. Hence, will contribute to the growth of the market.

A. Asia-pacific has the highest growth rate in the market which is growing due to the contribution of the emerging country. This is due to improvement in health awareness, development in healthcare infrastructure, and rise in number of hospitals & clinics equipped with advanced corneal implant medical facilities.

A. The cornea is the transparent part of the eye that covers the front portion of the eye

A. penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty and keratoprosthesis

A. The total market value of Global Artificial Cornea and Corneal Implant Market is $376.61 million in 2020.

A. The forcast period for Global Artificial Cornea and Corneal Implant Market is 2021 to 2028

A. The market value of Global Artificial Cornea and Corneal Implant Market in 2028 is $656.19 million.

A. The base year is 2020 in Artificial Cornea and Corneal Implant Market

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Artificial Cornea And Corneal Implant Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers